Rockville, Md. – Abt Associates has expanded the Opioid Quality Improvement (QI) Collaborative launched in March 2018 to a second cohort of healthcare systems. The Collaborative’s goal is to support healthcare systems in implementing recommendations from the CDC Guideline for Prescribing Opioids for Chronic Pain (CDC Guideline) and using associated QI measures to improve chronic pain care and opioid prescribing and management. Funded by the Centers for Disease Control and Prevention (CDC), the Collaborative now includes two cohorts of healthcare systems across 11 states from Massachusetts to Oregon and more than 120 primary care practices.
The second cohort of systems includes East Tennessee College of Nursing, Kettering Physician Network (OH), Owensboro Health (KY), University of Mississippi Medical Center, University of Utah Department of Family and Preventive Medicine and UPMC Pinnacle (PA). The first cohort includes: Atrius Health (MA), Indian Health Service (OR), Montefiore Medical Center (NY), St. Mary’s/Clearwater Valley (ID) and Stormont Vail Health (KS).
Integral to the project are 16 clinical QI opioid measures, which align with the CDC Guideline. Each healthcare system agreed to produce and monitor its progress on at least five QI measures. The healthcare systems will evaluate the impact of the QI measures on prescribing and patient outcomes.
The systems participating in the Collaborative will benefit from several resources and opportunities for shared learning:
- Expert guidance and consultation on clinical, QI and care redesign components of improving chronic pain care and opioid prescribing and management.
- Monthly implementation calls to discuss challenges and lessons learned.
- IT staff calls to discuss how to make the QI measures operational.
- A case-based clinical webinar series.
- Use of the CDC Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain.
- A website to identify resources and share information.
“The Collaborative is an opportunity to support healthcare systems that are doing the hard work in their communities to provide individualized care for patients with chronic pain,” says Sarah J. Shoemaker-Hunt, Ph.D., Pharm.D., “while balancing practice-level improvements in opioid prescribing for safer, evidence-based care.” Shoemaker-Hunt is the principal investigator for the CDC-funded project.
About Abt Associates
Abt Associates is an engine for social impact, dedicated to moving people from vulnerability to security. Harnessing the power of data and our experts’ insights, we provide research, consulting and technical services globally in the areas of health, environmental and social policy, technology and international development. http://www.abtassociates.com